Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CGI Inc. stock logo
GIB
CGI
$107.61
-0.2%
$104.61
$92.85
$122.79
$24.42B0.78202,308 shs121,648 shs
ICON Public Limited stock logo
ICLR
ICON Public
$134.97
-3.3%
$141.59
$125.10
$347.72
$10.90B1.151.07 million shs953,064 shs
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$147.15
-0.5%
$148.65
$134.65
$252.88
$25.46B1.281.59 million shs2.36 million shs
Trip.com Group Limited stock logo
TCOM
Trip.com Group
$61.95
+0.5%
$59.98
$38.23
$77.18
$40.46B0.093.96 million shs2.88 million shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CGI Inc. stock logo
GIB
CGI
+1.91%+0.72%+2.55%+4.09%+8.59%
ICON Public Limited stock logo
ICLR
ICON Public
+4.37%+6.70%-2.38%-24.61%-56.11%
IQVIA Holdings Inc. stock logo
IQV
IQVIA
+3.54%+6.65%-2.96%-20.30%-31.95%
Trip.com Group Limited stock logo
TCOM
Trip.com Group
-2.25%-2.44%+1.88%-2.98%+22.87%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CGI Inc. stock logo
GIB
CGI
3.6623 of 5 stars
3.61.01.70.02.91.72.5
ICON Public Limited stock logo
ICLR
ICON Public
4.2997 of 5 stars
4.33.00.00.02.43.32.5
IQVIA Holdings Inc. stock logo
IQV
IQVIA
4.8908 of 5 stars
4.43.00.04.62.71.72.5
Trip.com Group Limited stock logo
TCOM
Trip.com Group
4.5033 of 5 stars
2.63.01.72.52.81.73.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CGI Inc. stock logo
GIB
CGI
3.20
Buy$156.7545.67% Upside
ICON Public Limited stock logo
ICLR
ICON Public
2.60
Moderate Buy$213.0857.88% Upside
IQVIA Holdings Inc. stock logo
IQV
IQVIA
2.75
Moderate Buy$226.3253.81% Upside
Trip.com Group Limited stock logo
TCOM
Trip.com Group
3.17
Buy$77.2524.70% Upside

Current Analyst Ratings Breakdown

Latest ICLR, TCOM, GIB, and IQV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/23/2025
IQVIA Holdings Inc. stock logo
IQV
IQVIA
Redburn Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$188.00
5/22/2025
IQVIA Holdings Inc. stock logo
IQV
IQVIA
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral
5/21/2025
Trip.com Group Limited stock logo
TCOM
Trip.com Group
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$68.00 ➝ $70.00
5/20/2025
Trip.com Group Limited stock logo
TCOM
Trip.com Group
TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$67.00 ➝ $73.00
5/20/2025
Trip.com Group Limited stock logo
TCOM
Trip.com Group
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$80.00 ➝ $80.00
5/19/2025
IQVIA Holdings Inc. stock logo
IQV
IQVIA
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$232.00 ➝ $177.00
5/15/2025
ICON Public Limited stock logo
ICLR
ICON Public
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$200.00 ➝ $173.00
5/15/2025
IQVIA Holdings Inc. stock logo
IQV
IQVIA
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$210.00 ➝ $190.00
5/7/2025
IQVIA Holdings Inc. stock logo
IQV
IQVIA
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$195.00 ➝ $161.00
5/7/2025
IQVIA Holdings Inc. stock logo
IQV
IQVIA
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$255.00 ➝ $185.00
5/7/2025
IQVIA Holdings Inc. stock logo
IQV
IQVIA
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$170.00 ➝ $165.00
(Data available from 6/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CGI Inc. stock logo
GIB
CGI
$15.14B1.61$6.81 per share15.80$31.05 per share3.47
ICON Public Limited stock logo
ICLR
ICON Public
$8.19B1.33$13.12 per share10.29$115.44 per share1.17
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$15.50B1.64$12.60 per share11.68$34.45 per share4.27
Trip.com Group Limited stock logo
TCOM
Trip.com Group
$55.22B0.73$2.60 per share23.85$26.90 per share2.30
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CGI Inc. stock logo
GIB
CGI
$1.24B$5.4919.4817.132.5811.72%19.32%10.82%7/30/2025 (Estimated)
ICON Public Limited stock logo
ICLR
ICON Public
$612.34M$9.1814.178.831.869.56%11.81%6.65%7/23/2025 (Estimated)
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$1.37B$7.3419.6212.061.998.91%28.81%7.02%7/28/2025 (Estimated)
Trip.com Group Limited stock logo
TCOM
Trip.com Group
$1.40B$3.4518.5417.350.6731.86%12.04%6.70%N/A

Latest ICLR, TCOM, GIB, and IQV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2025Q1 2025
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$2.63$2.70+$0.07$1.40$3.77 billion$3.83 billion
4/30/2025Q2 2025
CGI Inc. stock logo
GIB
CGI
$1.50$1.48-$0.02$1.32$4.05 billion$2.80 billion
4/30/2025Q1 2025
ICON Public Limited stock logo
ICLR
ICON Public
$3.17$3.19+$0.02$1.90$2.03 billion$2.00 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CGI Inc. stock logo
GIB
CGI
$0.410.38%N/A7.47%N/A
ICON Public Limited stock logo
ICLR
ICON Public
N/AN/AN/AN/AN/A
IQVIA Holdings Inc. stock logo
IQV
IQVIA
N/AN/AN/AN/AN/A
Trip.com Group Limited stock logo
TCOM
Trip.com Group
$0.280.45%N/A8.12%N/A

Latest ICLR, TCOM, GIB, and IQV Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/1/2025
CGI Inc. stock logo
GIB
CGI
quarterly$0.10860.4%5/16/20255/16/20256/20/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CGI Inc. stock logo
GIB
CGI
0.28
1.31
1.04
ICON Public Limited stock logo
ICLR
ICON Public
0.36
1.26
1.34
IQVIA Holdings Inc. stock logo
IQV
IQVIA
2.12
0.84
0.84
Trip.com Group Limited stock logo
TCOM
Trip.com Group
0.14
1.42
1.42

Institutional Ownership

CompanyInstitutional Ownership
CGI Inc. stock logo
GIB
CGI
66.68%
ICON Public Limited stock logo
ICLR
ICON Public
95.61%
IQVIA Holdings Inc. stock logo
IQV
IQVIA
89.62%
Trip.com Group Limited stock logo
TCOM
Trip.com Group
35.41%

Insider Ownership

CompanyInsider Ownership
CGI Inc. stock logo
GIB
CGI
9.90%
ICON Public Limited stock logo
ICLR
ICON Public
44.00%
IQVIA Holdings Inc. stock logo
IQV
IQVIA
1.60%
Trip.com Group Limited stock logo
TCOM
Trip.com Group
22.98%
CompanyEmployeesShares OutstandingFree FloatOptionable
CGI Inc. stock logo
GIB
CGI
90,000226.73 million204.29 millionOptionable
ICON Public Limited stock logo
ICLR
ICON Public
41,10080.76 million46.20 millionOptionable
IQVIA Holdings Inc. stock logo
IQV
IQVIA
86,000173.00 million173.28 millionOptionable
Trip.com Group Limited stock logo
TCOM
Trip.com Group
33,700653.27 million496.08 millionOptionable

Recent News About These Companies

Trip.com Group Limited stock logo
Promising Leisure Stocks Worth Watching - June 5th
Despite Tourism Risks, Trip.Com Strikes Me As A Good Buy
Trip.com Group Limited stock logo
Leisure Stocks To Watch Today - May 29th

New MarketBeat Followers Over Time

Media Sentiment Over Time

CGI stock logo

CGI NYSE:GIB

$107.60 -0.17 (-0.15%)
As of 03:57 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

CGI Inc., together with its subsidiaries, provides information technology (IT) and business process services. Its services include the business and strategic IT consulting, systems integration, and software solutions. The company also provides application development, modernization and maintenance, holistic enterprise digitization, automation, hybrid and cloud management, and business process services; intellectual property-based solutions; business consulting; managed IT services; and IT infrastructure services. It serves clients operating in government, banking and capital market, health, utility, communication and media, oil and gas, space, manufacturing, insurance, life sciences, retail and consumer service, and transportation and logistics sectors. The company operates in Canada, France, Spain, Portugal, the United States, Germany, Sweden, Norway, the United Kingdom, Australia, Finland, Poland, Baltics, the Netherlands, Denmark, Czech Republic, India, the Philippines, Asia Pacific, and internationally. Western and Southern Europe; Australia; Scandinavia; Finland, Poland, and Baltics; the United States; the United Kingdom; and the Asia Pacific. The company was formerly known as CGI Group Inc. and changed its name to CGI Inc. in January 2019. CGI Inc. was founded in 1976 and is headquartered in Montreal, Canada.

ICON Public stock logo

ICON Public NASDAQ:ICLR

$134.97 -4.64 (-3.32%)
As of 03:57 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, it offers adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.

IQVIA stock logo

IQVIA NYSE:IQV

$147.15 -0.75 (-0.51%)
As of 03:57 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.

Trip.com Group stock logo

Trip.com Group NASDAQ:TCOM

$61.95 +0.32 (+0.52%)
As of 03:57 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Trip.com Group Limited, through its subsidiaries, operates as a travel service provider for accommodation reservation, transportation ticketing, packaged tours and in-destination, corporate travel management, and other travel-related services in China and internationally. The company acts as an agent for hotel-related transactions and selling air tickets, as well as provides train, long-distance bus, and ferry tickets; travel insurance products, such as flight delay, air accident, and baggage loss coverage; and air-ticket delivery, online check-in and seat selection, express security screening, real-time flight status tracker, and airport VIP lounge services. It also provides independent leisure travelers bundled packaged-tour products comprising group, semi-group, and customized and packaged tours with various transportation arrangements, including air, cruise, bus, and car rental services. In addition, the company offers integrated transportation and accommodation services; destination transportation and ticket, activity, insurance, visa, and tour guide services; user support, supplier management, and customer relationship management services; and in-destination products and services. Further, It provides its corporate clients with business visit, incentive trip, meeting and conference, travel data collection and analysis, and industry benchmarking solutions; and Corporate Travel Management System, an online platform that integrates information management, online booking and authorization, online inquiry, and travel reporting systems. Additionally, the company offers online advertising and financial services, such as marketing planning and travel media services. It operates under the Ctrip, Qunar, Trip.com, and Skyscanner brands. The company was formerly known as Ctrip.com International, Ltd. and changed its name to Trip.com Group Limited in October 2019. Trip.com Group Limited was founded in 1999 and is based in Singapore.